Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesTrajan Group Holdings Ltd

Trajan Group Holdings Ltd

Healthcare Medical Instruments & Supplies
PortfolioPortfolio WatchlistWatchlist
Company price
0.255 AUD 0.01 ( 4.08%)
Last update at 2026-11-06T03:42:00Z
VOLUME
50673
Market Cap
37.45M

Momentum Score

…

Trajan Group Holdings Limited develops and manufactures analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India. The company offers analytical products, including gas purifiers and filters, inlet liners, syringes, CB emitters, and tubing products, as well as columns, connections, septa, and inlet liners. It also provides sampling products comprising septa, caps, liners, well plates and sealing mats, crimping tools, and micro-sampling tools. In addition, the company provides pathology products, such as NBF containers; adhesive and frosted microscope slides; coverslips; microtome blades; biopsy pads; tissue marking dyes and sets; microscope slide storage trays/mailers; microscope slide and cassette storage boxes; and histology wax plus. Further, it offers analytical, automation, life sciences, sampling literature support products. The company was incorporated in 2011 and is headquartered in Ringwood, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.24
Low
0.26
High
52 Week Price Range
0.14
Low
0.74
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Trajan Group Holdings Ltd (ASX: TRJ) is limited, so available sources do not provide a clear, current description of its core operations or product lines. Because of this lack of detailed disclosure, material long-term growth drivers cannot be reliably identified, and investors should monitor updated financial reports and strategic announcements for clarity.
The principal investment risks are the scarcity of transparent disclosures and liquidity information, which increase uncertainty about the company’s financial condition, strategy execution and potential undisclosed operational or governance problems.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.24
Dividend Yield
-
Revenue TTM
161.38M
Revenue Per Share
1.06
Gross Profit TTM
59.95M
Debt / Equity
0.59
ROE
-0.61%
Net Debt
45.33M
ROCE
2.80%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -0.71M -1.73M -31.11M 5.47M 2.25M
Net income -0.62M -4.46M -25.33M 1.89M 1.70M
Selling general administrative - 47.91M 49.09M 47.70M 31.82M
Selling and marketing expenses - 0.87M 0.88M - 0.69M
Gross profit 16.86M 63.47M 59.75M 67.09M 42.63M
Reconciled depreciation - 6.35M 6.21M 5.36M 1.63M
Ebit 4.24M 1.80M -26.57M 9.43M 2.91M
Ebitda 12.96M 8.14M -20.36M 14.16M 4.54M
Depreciation and amortization 8.72M 6.35M 6.21M - 1.63M
Operating income 4.24M 3.48M 3.39M 9.43M 2.91M
Other operating expenses 157.14M 162.98M 154.30M 0.45M 101.95M
Interest expense 3.94M 3.53M 4.54M 3.32M 0.66M
Tax provision - 2.73M -5.78M 3.59M 0.55M
Interest income - 0.01M 0.08M 0.01M 0.00M
Net interest income - -4.29M -4.67M -4.00M -1.26M
Income tax expense -0.09M 2.73M -5.78M 3.59M 0.55M
Total revenue 161.38M 166.46M 155.02M 162.15M 107.57M
Total operating expenses 12.62M 59.99M 62.33M - 37.01M
Cost of revenue 144.52M 102.99M 95.27M 95.06M 64.94M
Total other income expense net -4.95M -5.21M -34.49M 0.05M -2.11M
Net income from continuing ops - -4.46M -25.33M 1.89M 1.70M
Net income applicable to common shares - -4.46M -25.33M 1.89M 1.70M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 183.94M 195.63M 188.00M 229.04M 206.78M
Intangible assets 24.44M 26.92M 29.05M 33.68M 3.98M
Other current assets 2.12M 3.02M 2.10M 0.33M 0.03M
Total liab 85.47M 90.01M 85.15M 99.51M 90.27M
Total stockholder equity 98.47M 105.62M 102.85M 129.53M 116.51M
Other current liab 14.78M 18.94M 14.59M 3.92M 15.20M
Common stock 102.44M 101.75M 101.47M 101.25M 96.26M
Capital stock - 101.75M 101.47M 101.25M 96.26M
Retained earnings -11.99M -12.00M -7.54M 18.62M 17.33M
Other liab - - - 10.77M 0.32M
Good will 56.41M 59.86M 57.15M 80.57M 103.43M
Other assets - - - 6.61M 4.34M
Cash 12.62M 11.85M 11.24M 11.04M 13.16M
Cash and equivalents - - - - 0.89M
Total current liabilities 32.68M 34.23M 72.15M 39.20M 80.15M
Current deferred revenue 1.38M - 1.21M - -
Net debt 45.33M 43.64M 44.92M 37.59M 53.02M
Short term debt 8.08M 4.16M 45.98M - 56.38M
Short long term debt - 1.66M 44.10M 9.93M 54.84M
Short long term debt total 57.95M 55.49M 56.16M - 66.18M
Other stockholder equity - - - 9.66M 2.92M
Property plant equipment - - - 35.22M 27.61M
Total current assets 67.35M 67.59M 61.71M 69.71M 64.86M
Long term investments - 0.14M 0.14M 1.55M 1.46M
Net tangible assets - - - 13.57M 8.01M
Net receivables 22.82M 23.59M 20.43M 24.16M 20.75M
Long term debt - 39.73M - 38.71M 0.00M
Inventory 29.78M 29.13M 27.93M 31.93M 28.27M
Accounts payable 8.44M 11.14M 10.38M 9.58M 8.57M
Accumulated other comprehensive income 8.01M 15.87M 8.92M - 2.92M
Non currrent assets other - - 29.05M - -
Non current assets total 116.60M 128.04M 126.29M 159.33M 141.91M
Capital lease obligations - 14.10M 12.06M 12.67M 11.34M
Long term debt total - - - - 9.80M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - -4.09M -3.04M -8.55M -1.31M
Change to liabilities - - - 2.61M 1.60M
Total cashflows from investing activities -3.42M -4.09M -3.04M -8.55M -116.38M
Net borrowings - -3.39M -4.53M -7.89M 45.58M
Total cash from financing activities 3.36M -5.64M -6.40M -3.36M 74.69M
Change to operating activities - - - 1.06M 1.51M
Net income -0.62M -4.46M -25.33M 1.89M 1.70M
Change in cash 0.77M 0.61M 0.20M -2.13M -38.55M
Begin period cash flow 11.85M 11.24M 11.04M 13.16M 51.72M
End period cash flow 12.62M 11.85M 11.24M 11.04M 13.16M
Total cash from operating activities 0.24M 10.83M 9.47M 9.55M 2.74M
Issuance of capital stock - - - 4.71M 29.97M
Depreciation 8.72M - 6.21M 7.90M 3.64M
Other cashflows from investing activities - - - - -112.97M
Dividends paid - - - - -49.22M
Change to inventory -0.66M - 4.01M -3.60M -4.72M
Change to account receivables 1.03M - 3.11M -3.17M -2.47M
Sale purchase of stock - - 0.00M -0.18M -0.86M
Other cashflows from financing activities -2.45M -2.26M -1.87M -0.18M 47.27M
Change to netincome - - - 1.61M 2.41M
Capital expenditures 3.42M 4.09M 3.04M 8.55M 3.42M
Change in working capital -6.13M -148.44M 7.85M - -101.41M
Stock based compensation - - 0.45M - -
Other non cash items -1.73M 10.83M 20.74M - -
Free cash flow -3.17M 6.74M 6.43M 1.00M -3.42M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
TRJ
Trajan Group Holdings Ltd		 0.01
4.08%		 0.26 - 20.00 0.23 0.37 0.51 9.13
RMD
Resmed Inc		 0.14
0.40%		 34.75 21.77 19.57 8.49 5.53 5.50 14.10
FPH
Fisher & Paykel Healthcare Corporation Ltd		 0.31
0.80%		 39.20 55.56 48.54 9.91 12.92 11.78 33.96
ANN
Ansell Ltd		 0.14
0.31%		 45.66 21.27 22.73 2.99 2.16 2.24 12.03
NAN
Nanosonics Ltd		 -0.06
2.03%		 2.89 49.17 78.12 4.33 4.02 3.64 24.30

Profile*

Trajan Group Holdings Ltd

Trajan Group Holdings Limited develops and manufactures analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India. The company offers analytical products, including gas purifiers and filters, inlet liners, syringes, CB emitters, and tubing products, as well as columns, connections, septa, and inlet liners. It also provides sampling products comprising septa, caps, liners, well plates and sealing mats, crimping tools, and micro-sampling tools. In addition, the company provides pathology products, such as NBF containers; adhesive and frosted microscope slides; coverslips; microtome blades; biopsy pads; tissue marking dyes and sets; microscope slide storage trays/mailers; microscope slide and cassette storage boxes; and histology wax plus. Further, it offers analytical, automation, life sciences, sampling literature support products. The company was incorporated in 2011 and is headquartered in Ringwood, Australia.

7 Argent Place, Ringwood, VIC, Australia, 3134

61 3 9837 4200

https://www.trajanscimed.com

620

Name Title Year Born
Mr. Stephen Tomisich CEO, MD & Director NA
Mr. Alister John Hodges CPA, CPA CFO & Company Sec. NA
Mr. Nigel Gilligan Chief Operations Officer NA
Dr. Andrew Arthur Gooley Chief Scientific Officer NA
Mr. Robert Lyon Exec. Director, Head of Corp. Devel. & Gen. Counsel NA
Mr. Sam Evans Sr. VP of Bus. Devel. NA
Ms. Helene Lajoie Chief HR Officer NA
Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSP Joint Company Sec. 1964
Mr. Alister John Hodges CPA, CPA CFO & Company Secretary NA
Mr. Robert Lyon Executive Director, Head of Corporate Development & General Counsel NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…